Envista Holdings Reports 11.5% Sales Growth in Q3 2025 Despite Net Loss

Envista Holdings Corporation reported its financial results for the third quarter and the first nine months of fiscal 2025, revealing a notable increase in sales and operational performance compared to the previous year. For the three months ended September 26, 2025, the company generated sales of $669.9 million, an 11.5% increase from $601.0 million in the same period of 2024. Gross profit for the quarter rose to $370.2 million, up 16.7% from $317.3 million, resulting in a gross margin of 55.3%. However, the company recorded a net loss of $30.3 million, compared to a net income of $8.2 million in the prior year, primarily due to a significant income tax expense of $80.2 million.

In the nine-month period, Envista's sales reached $1.968 billion, a 6.0% increase from $1.858 billion in 2024. The gross profit for this period was $1.076 billion, reflecting a 7.6% increase year-over-year. The operating profit for the nine months was $142.8 million, a significant recovery from an operating loss of $1.084 billion in the previous year, which was heavily impacted by goodwill and intangible asset impairments. The company attributed the improved performance to higher sales volumes and effective cost management, despite facing challenges such as increased tariffs and unfavorable foreign exchange rates.

Strategically, Envista has focused on expanding its product offerings and geographic reach. The company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. Sales in the Specialty Products & Technologies segment increased by 13.0% in the third quarter, driven by strong demand for dental implant systems and orthodontic products. The Equipment & Consumables segment also saw an 8.7% increase in sales, supported by higher demand in North America and China. The company continues to invest in research and development, with R&D expenses rising to $28.3 million for the quarter, reflecting a commitment to innovation.

Operationally, Envista reported a total of 166.1 million shares outstanding as of September 26, 2025, with a treasury stock position of $199 million. The company has also been active in managing its debt, with total liabilities amounting to $2.6 billion, including long-term debt of $1.445 billion. The company’s cash and cash equivalents increased to $1.134 billion, providing a solid liquidity position to support ongoing operations and strategic initiatives. Looking ahead, Envista anticipates continued growth driven by its focus on emerging markets and new product developments, while remaining vigilant to external economic factors that may impact its performance.